首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Method Development, Validation and Stability Indicating Studies for Simultaneous Estimation of Anti-Hypertensive Drugs from Pharmaceutical Formulation by RP-HPLC
【24h】

Method Development, Validation and Stability Indicating Studies for Simultaneous Estimation of Anti-Hypertensive Drugs from Pharmaceutical Formulation by RP-HPLC

机译:用RP-HPLC同时估算抗血血药物抗高血压药物的方法的开发,验证和稳定性

获取原文
           

摘要

Objective: Method development, validation & stability indicating studies for simultaneous estimation of Anti-Hypertensive drugs, Benidepine (BEN) and Metoprolol (MET) from pharmaceutical formulation by RP-HPLC. Methods: For present work, reverse phase chromatography was selected as its suggested use for ionic and moderate to non-polar compounds. Reverse phase chromatography is simple, suitable, better regarding efficiency, stability, and reproducibility. C18 packed column, a 100 X 2.1mm. ID column of 5.0 μm particle packing, was selected for separation of BEN and MET. Different solvent systems were tried and optimized in combinations as mobile phase. BEN (4 μg/ml) and MET (50 μg/ml) in 15mM ammonium formate-Methanol (15:85 v/v) was developed as it was showing good peak shapes and a significant amount of resolution. The mobile phase was flowed at 1.2 ml/min with detection of BEN analytes at 236 nm and MET analytes at 225 nm respectively. Result: Method development was done. Specificity, linearity, accuracy, precision, robustness, limit of detection and limit of quantitation were used to accomplish validation. The method was found linear from 32.5 – 500 μg.ml-1?for both BEN and MET individually. The percentage recovery of BEN when placed for period of 12 hours was found to 100% in 0.1N/M NaOH at 60?C and Thermal (60?C); 12 % degradation in 0.1N/M HCl at 60?C; Oxidation (3-6% H2O2) at room temperature whereas for MET was 100 % in 0.1N/M NaOH, 0.1N/M HCl at 60?C, at thermal (60?C) as well as oxidation by 3-6% H2O2 at room temperature.? Conclusion: Developed analytical method for the simultaneous estimation of Benidipine (BED) and Metoprolol (MET) in both bulk and tablet formulation has obliged the ICH guidelines including, tailing factor (T), separation factors (α), theoretical plates (N), capacity factor (k’), resolution (R) and RSD (%). The validated stress degradation studies under thermal, oxidative, alkali and acid ascertained few degradation products for Benidipine whereas the Metoprolol was unaffected with forced degradation studies.
机译:目的:方法开发,验证及稳定性指示用于通过RP-HPLC从药物制剂抗高血压药,Benidepine(BEN)和美托洛尔(MET)同时估计研究。方法:对于目前的工作中,逆相色谱法被选为其建议使用离子和中度到非极性化合物。反相色谱法简单,适合,更好关于效率,稳定性和再现性。 C18填充柱,100×2.1毫米。为5.0μm的颗粒堆积ID栏,被选择用于BEN和MET的分离。不同的溶剂系统进行了尝试和在组合作为流动相进行了优化。 BEN(4微克/毫升)和MET(50微克/毫升)在15mM的甲酸铵 - 甲醇(15:85 V / V)的开发是因为它是表现出良好的峰形状和分辨率的显著量。流动相在236nm处为1.2毫升/分钟的检测BEN分析物的流动和MET在225nm处分别的分析物。结果:方法的发展已完成。特异性,线性,准确度,精密度,鲁棒性,检测和定量的极限的极限被用来完成验证。该方法从32.5发现线性 - 500μg.ml-1两者BEN和MET单独?。当放置12小时期间BEN的回收百分比在60发现100%在0.1N / M的NaOH C和热(60℃?)?;在0.1N / M的HCl 12%降解,在60℃?;氧化(3-6%H 2 O 2)在室温下,而对于MET是在0.1N / M的NaOH,0.1N / M的HCl 100%,在60 C,在热(60℃)以及氧化由3-6% H2O2在室温下?结论:开发用于贝尼地平(床)和美托洛尔(MET)的以散装和片剂制剂的同时估计的分析方法已经不得不ICH指南包括拖尾因子(T),分离因子(α),理论塔板数(N),容量因子(K'),分辨率(R)和RSD(%)。下热,氧化验证的应力降解研究,碱和酸数确定降解产物为贝尼地平,而美托洛尔未受影响与强制降解研究。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号